For example, epidermal growth factor receptor (EGFR) mutations or EGFR overexpression can be detected in non-small-cell lung cancer (NSCLC) patients, leading to the aberrant growth, metastasis, and resistance development of cancer cells [3]. Here, EGFR is linked to non-small cell lung carcinoma.